gabapentin has been researched along with Altitude Sickness in 4 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Altitude Sickness: Multiple symptoms associated with reduced oxygen at high ALTITUDE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Headache is the most prevalent symptom of acute mountain sickness." | 6.73 | Low-dose gabapentin in treatment of high-altitude headache. ( Gorouhi, F; Jafarian, S; Lotfi, J; Salimi, S, 2007) |
| "Gabapentin was effective for the prevention of HAH and had satisfactory tolerability." | 6.73 | Gabapentin for prevention of hypobaric hypoxia-induced headache: randomized double-blind clinical trial. ( Abolfazli, R; Gorouhi, F; Jafarian, S; Lotfi, J; Rezaie, S, 2008) |
| "Headache is the most prevalent symptom of acute mountain sickness." | 2.73 | Low-dose gabapentin in treatment of high-altitude headache. ( Gorouhi, F; Jafarian, S; Lotfi, J; Salimi, S, 2007) |
| "Gabapentin was effective for the prevention of HAH and had satisfactory tolerability." | 2.73 | Gabapentin for prevention of hypobaric hypoxia-induced headache: randomized double-blind clinical trial. ( Abolfazli, R; Gorouhi, F; Jafarian, S; Lotfi, J; Rezaie, S, 2008) |
| "Acetazolamide was associated with a reduction in acute mountain sickness symptoms, with a number needed to treat ranging from 8 to 3 among 3 trials and at doses ranging from 250 to 750 mg daily." | 2.48 | Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review. ( Emmett, TW; Malka, ST; Seupaul, RA; Welch, JL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simancas-Racines, D | 1 |
| Arevalo-Rodriguez, I | 1 |
| Osorio, D | 1 |
| Franco, JV | 1 |
| Xu, Y | 1 |
| Hidalgo, R | 1 |
| Seupaul, RA | 1 |
| Welch, JL | 1 |
| Malka, ST | 1 |
| Emmett, TW | 1 |
| Jafarian, S | 2 |
| Gorouhi, F | 2 |
| Salimi, S | 1 |
| Lotfi, J | 2 |
| Abolfazli, R | 1 |
| Rezaie, S | 1 |
2 reviews available for gabapentin and Altitude Sickness
| Article | Year |
|---|---|
Interventions for treating acute high altitude illness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Altitude Sickness; Amines; Anticonvulsants; Atmosph | 2018 |
Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review.
Topics: Acetazolamide; Altitude Sickness; Amines; Carbonic Anhydrase Inhibitors; Cyclohexanecarboxylic Acids | 2012 |
2 trials available for gabapentin and Altitude Sickness
| Article | Year |
|---|---|
Low-dose gabapentin in treatment of high-altitude headache.
Topics: Adolescent; Adult; Altitude Sickness; Amines; Analgesics; Cyclohexanecarboxylic Acids; Double-Blind | 2007 |
Gabapentin for prevention of hypobaric hypoxia-induced headache: randomized double-blind clinical trial.
Topics: Adolescent; Adult; Aged; Altitude Sickness; Amines; Cyclohexanecarboxylic Acids; Disorders of Excess | 2008 |